Americas

Study Discovers Receptor that May Reduce Necessity for Chemo and Radiation Pre-T Cell Therapy

According to UCLA scientists working with Stanford and University of Pennsylvania experts, a synthetic IL-9 receptor permits cancer-fighting T cells to accomplish their job without the usage of chemo or radiation.